Clinical performance of the 3M Rapid Detection Flu A plus B Test compared to R-Mix culture, DFA and BinaxNOW Influenza A&B Test
Clinical performance of the 3M Rapid Detection Flu A plus B Test compared to R-Mix culture, DFA and BinaxNOW Influenza A&B Test
复制标题
DOI:
10.1016/j.jcv.2009.03.018
复制
发表时间:
2009-06-01
影响因子:
8.8
通讯作者:
Manji, Ryhana
中科院分区:
文献类型:
--
作者:
Ginocchio, Christine C.;Lotlikar, Madhavi;Manji, Ryhana
Background: The rapid diagnosis of influenza allows for prompt patient management and the initiation of appropriate infection control measures to reduce spread in healthcare settings.Objective: To evaluate the clinical performance of the 3M Rapid Detection Flu A+B Test (3MA+B) as compared to R-Mix cell culture, direct immunofluorescence assay (DFA) and the BinaxNOW A&B Influenza Test (BinaxNOW).Study design: Five hundred fresh respiratory samples, collected from patients aged 5 days to 99 years with respiratory symptoms, were tested by R-Mix culture, DFA, 3MA+B and BinaxNOW. Analytical sensitivity of 3MA+B was compared to BinaxNOW using replicates of serially diluted clinical samples positive for influenza A or B.Results: Sensitivity, specificity, PPV and NPV for the detection of influenza A and B, respectively, were for R-Mix (96.9%, 100%, 100%, 99.3%; 98.1%, 100%, 100%, 99.8%), DFA (80.4%. 99.2%, 96.1%, 95.3%; 74%, 100%, 100%, 97%), 3MA+B (70.1%, 99.8%, 98.6%, 93%; 86.5%, 98.7%, 88.2%, 98.4%) and BinaxNOW (46.4%, 100%, 100%. 88.6%; 34.6%, 100%, 100%, 93%). R-Mix, DFA and 3MA+B were significantly (P